These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4089215)

  • 1. Apolipoproteins, the lipid hypothesis and ischaemic heart disease.
    Avogaro P
    Przegl Lek; 1985; 42(8):602-6. PubMed ID: 4089215
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoproteins--important discriminators for atherosclerotic vascular disease.
    Mordasini R; Riesen WF
    Monogr Atheroscler; 1986; 14():145-9. PubMed ID: 3736553
    [No Abstract]   [Full Text] [Related]  

  • 3. [Genetic factors in ischemic heart disease].
    Slavchev S
    Vutr Boles; 1986; 25(3):12-9. PubMed ID: 3532554
    [No Abstract]   [Full Text] [Related]  

  • 4. Apoproteins B and A-I and coronary artery disease in humans.
    Brunzell JD; Sniderman AD; Albers JJ; Kwiterovich PO
    Arteriosclerosis; 1984; 4(2):79-83. PubMed ID: 6422918
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis.
    Alaupovic P
    Ann Biol Clin (Paris); 1980; 38(2):83-93. PubMed ID: 6992659
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipids, lipoproteins, apolipoproteins, and atherosclerosis.
    Kreisberg RA
    Ann Intern Med; 1983 Nov; 99(5):713-5. PubMed ID: 6638729
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)].
    Krempler F
    Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The oxidative hypothesis of atherosclerosis and the use of antioxidants in coronary disease].
    Batlouni M
    Arq Bras Cardiol; 1997 Jan; 68(1):55-63. PubMed ID: 9334462
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lipid evaluation of coronary patients before and after physical rehabilitation].
    Elkhiari D; Kallel R; Fki M; Jebri A; Ben Hamida A; Mebazaa A
    Tunis Med; 1992 Feb; 70(2):87-90. PubMed ID: 1496740
    [No Abstract]   [Full Text] [Related]  

  • 11. [Less well-known lipid "risk" factors of arteriosclerosis].
    Pagnan A; Zanetti G; Guarini P; Dal Palú C
    G Clin Med; 1980 Aug; 61(8):593-600. PubMed ID: 7004983
    [No Abstract]   [Full Text] [Related]  

  • 12. Retention of atherogenic lipoproteins in atherogenesis.
    Gustafsson M; Flood C; Jirholt P; Borén J
    Cell Mol Life Sci; 2004 Jan; 61(1):4-9. PubMed ID: 14704849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of apolipoprotein E gene plasma levels of lipids, lipoproteins, apolipoproteins and its relation with coronary heart disease].
    Zhu T; Wang Z; Zhao S
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):149-51. PubMed ID: 10681829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherogenic lipid profile in elderly patients with ischaemic cerebrovascular disease.
    Cuchel M; Stott DJ; Gaw A; Vergani C; Packard CJ
    Lancet; 2000 Jul; 356(9227):401-2. PubMed ID: 10972378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apolipoproteins and screening for coronary atherosclerosis].
    Cano Y; Malandain H
    Presse Med; 1983 Apr; 12(19):1236. PubMed ID: 6221307
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory].
    Zöllner N; Keller C
    Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of serum lipids in relation to age, overweight and ischaemic heart disease.
    Soukupová K; Fabián F; Heyrovský A; Reinis Z; Stuchlíková E; Sindelárová I
    Acta Univ Carol Med (Praha); 1969; 15(7):633-40. PubMed ID: 5372271
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma lipids in normal subjects, and in patients with coronary disease and peripheral arteriopathy].
    Rusconi C; Gola E; Arosio G; Riva S; Frau G; Albertini A; Prandini BD; Spandrio L
    Minerva Med; 1973 Nov; 64(80):4209-16. PubMed ID: 4765428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.